Rockefeller Capital Management
OCDX

Rockefeller Capital Management’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

Rockefeller Capital Management’s Portfolio OCDX Stock Details OCDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-81
Closed -$1K – 4558
2022
Q1 		$1K Sell
81
-250
-76% -$4.5K ﹤0.01% 3829
2021
Q4 		$7K Buy
331
+61
+23% +$1.2K ﹤0.01% 3172
2021
Q3 		$4K Buy
270
+250
+1,250% +$5.03K ﹤0.01% 3291
2021
Q2 		$0 Buy
+20
New +$407 ﹤0.01% 3685

Other funds holding OCDX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Rockefeller Capital Management's OCDX Position: Q2 2022 in Review

Rockefeller Capital Management sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q2 2022, closing a stake of 81 shares — an estimated $1K sold.

Rockefeller Capital Management first reported a position in OCDX in Q2 2021 and held it in 4 quarters. The position peaked at $7K in Q4 2021. 1 fund tracked by Wall St. Rank holds OCDX as of Q2 2022.

  • Rockefeller Capital Management reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q2 2022 after selling out during the quarter.
  • Rockefeller Capital Management sold 81 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q2 2022, an estimated $1K.
  • Rockefeller Capital Management first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q2 2021 and held it in 4 quarters.
  • Rockefeller Capital Management's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $7K in Q4 2021.
  • 1 fund tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q2 2022.

Based on Rockefeller Capital Management's 13F filing for Q2 2022, filed 12 Aug 2022.